AKER BIOMARINE Fornebu,July 3, 2024 - Reference is made to the stock exchange notice byAker BioMarine ASA ("AKBM") today regarding the sale of its ownership position in the Feed Ingredients business to a new company to be established ("Aker BioMarine Antarctic Holding II AS") owned 60% byAmerican Industrial Partners ("AIP") and 40% byAker ASA (via its wholly owned subsidiaryAker Capital AS , hereinafter "Aker"). InFebruary 2024 ,Aker BioMarine announced a strategic review of its ownership position in the Feed Ingredients business. The transaction is an important step in crystallizing value and enabling a more focusedAker BioMarine . Based onAker BioMarine's estimated excess cash following closing,Aker BioMarine is planning to pay an extraordinary dividend ofNOK 35 toNOK 45 per share. Accordingly, Aker expects to receive gross cash proceeds betweenNOK 2.4 andNOK 3.1 billion , subject to final purchase price adjustments and the contemplated refinancing ofAker BioMarine . After an equity investment in Aker BioMarine Antarctic Holding II AS in the area ofNOK 1.4 billion and a shareholder loan in the area ofNOK 200 million to the acquired entity, Aker will realize net cash proceeds betweenNOK 0.8 andNOK 1.5 billion from the transaction. Aker will participate in the further value creation of the Feed Ingredients business through its 40 percent ownership inAker BioMarine Antarctic Holding II AS. By partnering with and investing together with AIP, Aker will ensure a continued focus on krill-based ingredients for fish- and animal feed in a jointly owned company. Aker will continue its efforts to further streamline and focusAker BioMarine within the human health and nutrition business as a 78% shareholder inAker BioMarine . Closing of the transaction is expected during the third quarter of 2024, subject to obtaining the necessary competition clearances. For further information and details about the transaction and terms, please refer toAker BioMarine ASA's stock exchange announcement from today, available atAker BioMarine's ticker "AKBM" on: www.newsweb.no and at www.akerbiomarine.no -END- Media contact:Atle Kigen , Head of Media Relations and Public Affairs,Aker ASA Tel: +47 90 78 48 78 Email: atle.kigen@akerasa.com Investor contacts:Fredrik Berge , Head of Investor Relations,Aker ASA Tel: +47 45 03 20 90 Email: fredrik.berge@akerasa.comChristopher Robin Vinter , VP IR & Corporate Finance,Aker BioMarine ASA Tel: +47 91 16 08 20 Email: christopher.vinter@akerbiomarine.com This information is considered to be inside information pursuant to the EU Market Abuse Regulation article 7 and is subject to the disclosure requirements pursuant to MAR article 17 and Section 5-12 the Norwegian Securities Trading Act. Thisstock exchange announcement was published byLaila Hop , Paralegal,Aker ASA , onJuly 3, 2024 , at20:01 CEST .
Click here for more information
© Oslo Bors ASA, source
